Ozempic, Wegovy, Mounjaro and Zepbound May Fuel Rare Brain Disorder, Study Finds

Ozempic, Wegovy, Mounjaro and Zepbound May Fuel Rare Brain Disorder, Study Finds

Credit: iStock

Text

Updated Sep 15, 2026 | 09:00 AM IST

SummaryPublished in Clinical Nutrition, the study identified 15 cases of Wernicke’s encephalopathy (WE) among people taking GLP-1 medications containing semaglutide or tirzepatide. It was linked deficiency caused by GLP-1 drugs, in particularly of vitamin B1, also known as thiamine.

End of Article